et al. presented a case of phaeochromocytoma crisis manifesting as catecholamine cardiomyopathy in a recent issue of the journal. 1 I would like to suggest that magnesium sulphate should be considered as a treatment option in the ED when phaeochromocytoma is considered as a possible cause of severe hypertension or cardiomyopathy.Magnesium reduces catecholamine release, is a highly effective alpha-adrenergic antagonist and antiarrhythmic in the setting of large-dose epinephrine infusions, and is predominantly an arteriolar dilator with minimal effects on pulmonary capillary wedge pressure and venous return. 2,3 It is readily available and simple to use. There is extensive literature on the efficacy of magnesium sulphate in the management of hypertension and arrhythmias during surgical removal of phaeochromocytoma, often without preceding alpha-blockade. Several case reports describe its successful use in individuals with phaeochromocytoma crisis, including catecholamine cardiomyopathy, where phentolamine and nitroprusside were unsuccessful. 4,5 In conclusion, emergency physicians should be aware of magnesium sulphate as a treatment option when a phaeochromocytoma crisis is considered.
References1. Clarke B, Ryan G, Fraser J, Francis L. Uncommon cause of cardiac arrest in the emergency department. Emerg. Med. Australas 2007; 19: 169-72. 2. James MF, Beer RE, Esser JD. Intravenous magnesium sulphate inhibits catecholamine release associated with tracheal intubation. Anesth. Analg. 1989; 68: 772-6. 3. James MFM, Cork RC, Harlen GN, White JF. Interactions of adrenaline and magnesium on the cardiovascular system of the baboon. Magnesium 1988; 7: 37-43. 4. James MF, Cronje L. Pheochromocytoma crisis: the use of magnesium sulphate.